We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106B
AUM Growth
+$3.62B
(+3.5%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$743M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$215M |
| 3 |
Chevron
CVX
|
+$189M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$161M |
| 5 |
Meta Platforms (Facebook)
META
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$281M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$219M |
| 4 |
Eli Lilly
LLY
|
+$212M |
| 5 |
RTX Corp
RTX
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.44% |
| 2 | Healthcare | 15.11% |
| 3 | Industrials | 11.28% |
| 4 | Energy | 10.95% |
| 5 | Technology | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Pebblebrook Hotel Trust
PEB
$2.16B
| $2.04M | ﹤0.01% |
55,092
+4,854
| +10% | +$170K |
|
1152
Corpay
CPAY
$24.2B
| $2.03M | ﹤0.01% |
15,374
-1,915
| -11% | -$234K |
|
|
VXRT
1153
DELISTED
Vaxart
VXRT
| $2.02M | ﹤0.01% |
64,427
-91
| -0.1% | -$3.8K |
|
|
AENZ
1154
DELISTED
Aenza S.A.A.
AENZ
| $2.02M | ﹤0.01% |
37,333
-334
| -0.9% | -$17.1K |
|
|
DYN
1155
DELISTED
Dynegy, Inc.
DYN
| $2.01M | ﹤0.01% |
57,676
-8,773
| -13% | -$271K |
|
|
CSOD
1156
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $2M | ﹤0.01% |
43,477
+15,129
| +53% | +$616K |
|
|
QEP
1157
DELISTED
QEP RESOURCES, INC.
QEP
| $1.99M | ﹤0.01% |
57,805
+3,491
| +6% | +$110K |
|
|
RVNC
1158
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.99M | ﹤0.01% |
58,582
+8,916
| +18% | +$279K |
|
|
SCLN
1159
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $1.99M | ﹤0.01% |
378,087
-254,936
| -40% | -$1.24M |
|
|
OME
1160
DELISTED
Omega Protein
OME
| $1.96M | ﹤0.01% |
143,577
-1,604
| -1% | -$21K |
|
|
CA
1161
DELISTED
CA, Inc.
CA
| $1.96M | ﹤0.01% |
68,135
-345,917
| -84% | -$10.2M |
|
1162
Belden
BDC
$4B
| $1.95M | ﹤0.01% |
24,971
-4,312
| -15% | -$316K |
|
|
ADMS
1163
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.95M | ﹤0.01% |
+106,673
| New | +$1.91M |
|
|
AEGR
1164
DELISTED
Aegerion Pharmaceuticals
AEGR
| $1.94M | ﹤0.01% |
60,350
-233,642
| -79% | -$8.7M |
|
1165
SK Telecom
SKM
$13.7B
| $1.93M | ﹤0.01% |
45,201
+18,159
| +67% | +$708K |
|
1166
Generac Holdings
GNRC
$11.9B
| $1.92M | ﹤0.01% |
39,484
-171,198
| -81% | -$9.01M |
|
|
RNA
1167
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $1.91M | ﹤0.01% |
150,900
-300
| -0.2% | -$2.44K |
|
1168
Pacira BioSciences
PCRX
$1.02B
| $1.9M | ﹤0.01% |
20,690
+64
| +0.3% | +$4.87K |
|
1169
YPF
YPF
$20.2B
| $1.9M | ﹤0.01% |
+58,000
| New | +$1.77M |
|
1170
Vail Resorts
MTN
$5.19B
| $1.88M | ﹤0.01% |
24,313
+315
| +1% | +$22.1K |
|
|
FMER
1171
DELISTED
FIRSTMERIT CORP
FMER
| $1.86M | ﹤0.01% |
94,293
-15,720
| -14% | -$308K |
|
|
BSTC
1172
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.86M | ﹤0.01% |
69,035
-31,251
| -31% | -$814K |
|
1173
Agnico Eagle Mines
AEM
$72.6B
| $1.85M | ﹤0.01% |
48,400
| – | – |
|
1174
United Natural Foods
UNFI
$3.01B
| $1.85M | ﹤0.01% |
28,461
-4,449
| -14% | -$298K |
|
|
WP
1175
DELISTED
Worldpay, Inc.
WP
| $1.84M | ﹤0.01% |
54,851
+33,200
| +153% | +$1.02M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
- BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
- BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
- BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
- BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
- BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
- BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
- BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.
Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.